Oaktree Acquisition Corp. III Life Sciences (OACC) Accumulated Expenses (2024 - 2025)
Oaktree Acquisition Corp. III Life Sciences filings provide 2 years of Accumulated Expenses readings, the most recent being -$90000.0 for Q3 2025.
- Quarterly Accumulated Expenses changed N/A to -$90000.0 in Q3 2025 from the year-ago period, while the trailing twelve-month figure was -$90000.0 through Sep 2025, changed N/A year-over-year, with the annual reading at -$179984.0 for FY2024, N/A changed from the prior year.
- Accumulated Expenses hit -$90000.0 in Q3 2025 for Oaktree Acquisition Corp. III Life Sciences, roughly flat from -$90000.0 in the prior quarter.
- Across five years, Accumulated Expenses topped out at -$90000.0 in Q2 2025 and bottomed at -$179984.0 in Q4 2024.